South East Angels portfolio company Siloton is officially the first to capture an OCT image of a live human eye using a photonic chip 🚀
We are incredibly proud to announce that Siloton is the first company to capture an OCT image of a live human eye using a photonic chip. This is the result of months of deep technical work characterizing our first-generation OCT chip, Akepa, and developing the custom optical assembly to perform eye imaging. This is an impressive achievement in any context, but it is especially momentous given the resources of a small independent start up. Despite this being Siloton's first chip design, it is already capable of producing clinically-relevant data pertinent to the diagnosis of common eye diseases. This marks a major milestone for Siloton. Until now, we have been focused on demonstrating that chip-OCT is possible using commercially-viable supply chains and costs. Moving forward, we will be focusing on improved performance and self-imaging automation as we accelerate toward patient trials. The Siloton team continue to be focused on using this advanced technology to ensure that everyone can access OCT technology, whenever and where ever it is needed. Be sure to follow Siloton in LinkedIn and sign up to our newsletter to get the latest updates. Thanks to those individuals and institutions that have helped us reach this point. Find out more 👉 https://lnkd.in/e6M6hza4 #healthtech #deeptech #bristol #ophthalmology #oct #eye #investment #venturecapital